Literature DB >> 24994904

Alteration of the lipid profile in lymphomas induced by MYC overexpression.

Livia S Eberlin1, Meital Gabay2, Alice C Fan2, Arvin M Gouw2, Robert J Tibshirani3, Dean W Felsher2, Richard N Zare4.   

Abstract

Overexpression of the v-myc avian myelocytomatosis viral oncogene homolog (MYC) oncogene is one of the most commonly implicated causes of human tumorigenesis. MYC is known to regulate many aspects of cellular biology including glucose and glutamine metabolism. Little is known about the relationship between MYC and the appearance and disappearance of specific lipid species. We use desorption electrospray ionization mass spectrometry imaging (DESI-MSI), statistical analysis, and conditional transgenic animal models and cell samples to investigate changes in lipid profiles in MYC-induced lymphoma. We have detected a lipid signature distinct from that observed in normal tissue and in rat sarcoma-induced lymphoma cells. We found 104 distinct molecular ions that have an altered abundance in MYC lymphoma compared with normal control tissue by statistical analysis with a false discovery rate of less than 5%. Of these, 86 molecular ions were specifically identified as complex phospholipids. To evaluate whether the lipid signature could also be observed in human tissue, we examined 15 human lymphoma samples with varying expression levels of MYC oncoprotein. Distinct lipid profiles in lymphomas with high and low MYC expression were observed, including many of the lipid species identified as significant for MYC-induced animal lymphoma tissue. Our results suggest a relationship between the appearance of specific lipid species and the overexpression of MYC in lymphomas.

Entities:  

Keywords:  biostatistics; cancer; lipidomics; metabolomics; transgenic models

Mesh:

Substances:

Year:  2014        PMID: 24994904      PMCID: PMC4115527          DOI: 10.1073/pnas.1409778111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

Review 1.  myc function and regulation.

Authors:  K B Marcu; S A Bossone; A J Patel
Journal:  Annu Rev Biochem       Date:  1992       Impact factor: 23.643

Review 2.  Conditional transgenic models define how MYC initiates and maintains tumorigenesis.

Authors:  Constadina Arvanitis; Dean W Felsher
Journal:  Semin Cancer Biol       Date:  2006-07-21       Impact factor: 15.707

3.  Increased intracellular glycerophosphoinositol is a biochemical marker for transformation by membrane-associated and cytoplasmic oncogenes.

Authors:  T Alonso; E Santos
Journal:  Biochem Biophys Res Commun       Date:  1990-08-31       Impact factor: 3.575

Review 4.  Otto Warburg's contributions to current concepts of cancer metabolism.

Authors:  Willem H Koppenol; Patricia L Bounds; Chi V Dang
Journal:  Nat Rev Cancer       Date:  2011-04-14       Impact factor: 60.716

5.  Reversible tumorigenesis by MYC in hematopoietic lineages.

Authors:  D W Felsher; J M Bishop
Journal:  Mol Cell       Date:  1999-08       Impact factor: 17.970

6.  Carnitine-acyltransferase system inhibition, cancer cell death, and prevention of myc-induced lymphomagenesis.

Authors:  Annalisa Pacilli; Maria Calienni; Sabrina Margarucci; Maria D'Apolito; Orsolina Petillo; Laura Rocchi; Gianandrea Pasquinelli; Raffaella Nicolai; Aleardo Koverech; Menotti Calvani; Gianfranco Peluso; Lorenzo Montanaro
Journal:  J Natl Cancer Inst       Date:  2013-03-13       Impact factor: 13.506

7.  Transformation by the k-ras oncogene correlates with increases in phospholipase A2 activity, glycerophosphoinositol production and phosphoinositide synthesis in thyroid cells.

Authors:  S Valitutti; P Cucchi; G Colletta; C Di Filippo; D Corda
Journal:  Cell Signal       Date:  1991       Impact factor: 4.315

8.  Correlation of fatty acyl composition of mitochondrial and microsomal phospholipid with growth rate of rat hepatomas.

Authors:  J W Hartz; R E Morton; M M Waite; H P Morris
Journal:  Lab Invest       Date:  1982-01       Impact factor: 5.662

9.  Nanofluidic proteomic assay for serial analysis of oncoprotein activation in clinical specimens.

Authors:  Alice C Fan; Debabrita Deb-Basu; Mathias W Orban; Jason R Gotlib; Yasodha Natkunam; Roger O'Neill; Rose-Ann Padua; Liwen Xu; Daryl Taketa; Amy E Shirer; Shelly Beer; Ada X Yee; David W Voehringer; Dean W Felsher
Journal:  Nat Med       Date:  2009-04-12       Impact factor: 53.440

10.  An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets.

Authors:  Karen I Zeller; Anil G Jegga; Bruce J Aronow; Kathryn A O'Donnell; Chi V Dang
Journal:  Genome Biol       Date:  2003-09-11       Impact factor: 13.583

View more
  50 in total

1.  A MALDI-MSI Approach to the Characterization of Radiation-Induced Lung Injury and Medical Countermeasure Development.

Authors:  Claire L Carter; Jace W Jones; Kory Barrow; Kaitlyn Kieta; Cheryl Taylor-Howell; Sean Kearney; Cassandra P Smith; Allison Gibbs; Ann M Farese; Thomas J MacVittie; Maureen A Kane
Journal:  Health Phys       Date:  2015-11       Impact factor: 1.316

2.  Ambient Molecular Analysis of Biological Tissue Using Low-Energy, Femtosecond Laser Vaporization and Nanospray Postionization Mass Spectrometry.

Authors:  Fengjian Shi; Paul M Flanigan; Jieutonne J Archer; Robert J Levis
Journal:  J Am Soc Mass Spectrom       Date:  2015-12-14       Impact factor: 3.109

3.  Oncogene KRAS activates fatty acid synthase, resulting in specific ERK and lipid signatures associated with lung adenocarcinoma.

Authors:  Arvin M Gouw; Livia S Eberlin; Katherine Margulis; Delaney K Sullivan; Georgia G Toal; Ling Tong; Richard N Zare; Dean W Felsher
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-11       Impact factor: 11.205

4.  Deregulated Myc requires MondoA/Mlx for metabolic reprogramming and tumorigenesis.

Authors:  Patrick A Carroll; Daniel Diolaiti; Lisa McFerrin; Haiwei Gu; Danijel Djukovic; Jianhai Du; Pei Feng Cheng; Sarah Anderson; Michelle Ulrich; James B Hurley; Daniel Raftery; Donald E Ayer; Robert N Eisenman
Journal:  Cancer Cell       Date:  2015-01-29       Impact factor: 31.743

5.  The MYC Oncogene Cooperates with Sterol-Regulated Element-Binding Protein to Regulate Lipogenesis Essential for Neoplastic Growth.

Authors:  Arvin M Gouw; Katherine Margulis; Natalie S Liu; Sudha J Raman; Anthony Mancuso; Georgia G Toal; Ling Tong; Adriane Mosley; Annie L Hsieh; Delaney K Sullivan; Zachary E Stine; Brian J Altman; Almut Schulze; Chi V Dang; Richard N Zare; Dean W Felsher
Journal:  Cell Metab       Date:  2019-08-22       Impact factor: 27.287

Review 6.  Visualizing life with ambient mass spectrometry.

Authors:  Cheng-Chih Hsu; Pieter C Dorrestein
Journal:  Curr Opin Biotechnol       Date:  2014-08-20       Impact factor: 9.740

Review 7.  MYC and tumor metabolism: chicken and egg.

Authors:  Francesca R Dejure; Martin Eilers
Journal:  EMBO J       Date:  2017-11-10       Impact factor: 11.598

8.  Atmospheric pressure MALDI mass spectrometry imaging of tissues and cells at 1.4-μm lateral resolution.

Authors:  Mario Kompauer; Sven Heiles; Bernhard Spengler
Journal:  Nat Methods       Date:  2016-11-14       Impact factor: 28.547

Review 9.  Mass spectrometry imaging to detect lipid biomarkers and disease signatures in cancer.

Authors:  Matthias Holzlechner; Eliseo Eugenin; Brendan Prideaux
Journal:  Cancer Rep (Hoboken)       Date:  2019-12

10.  Ambient ionization mass spectrometric analysis of human surgical specimens to distinguish renal cell carcinoma from healthy renal tissue.

Authors:  Clint M Alfaro; Alan K Jarmusch; Valentina Pirro; Kevin S Kerian; Timothy A Masterson; Liang Cheng; R Graham Cooks
Journal:  Anal Bioanal Chem       Date:  2016-05-20       Impact factor: 4.142

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.